Annexon Inc (ANNX)

NASDAQ
Currency in USD
2.800
+0.030(+1.08%)
Closed·
After Hours
2.810+0.010(+0.357%)
·
ANNX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
1.8502.965
52 wk Range
1.2857.850
Key Statistics
Edit
Prev. Close
2.77
Open
2.77
Day's Range
1.85-2.965
52 wk Range
1.285-7.85
Volume
8M
Average Vol. (3m)
1.63M
1-Year Change
-44.44%
Book Value / Share
2.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANNX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.600
Upside
+314.29%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Annexon Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Annexon Inc Company Profile

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company’s lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington’s disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Compare ANNX to Peers and Sector

Metrics to compare
ANNX
Peers
Sector
Relationship
P/E Ratio
−1.8x−4.5x−0.5x
PEG Ratio
−0.120.020.00
Price / Book
1.3x3.2x2.6x
Price / LTM Sales
-8.8x3.1x
Upside (Analyst Target)
297.1%140.4%45.7%
Fair Value Upside
Unlock10.6%5.7%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.600
(+314.29% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.37 / -0.30
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ANNX Income Statement

People Also Watch

6.11
TNGX
+1.16%
9.69
PHAT
+3.42%
6.260
NVTS
-2.64%
5.660
BTM
-0.35%
2.270
ARMP
+2.25%

FAQ

What Is the Annexon (ANNX) Stock Price Today?

The Annexon stock price today is 2.80

What Stock Exchange Does Annexon Trade On?

Annexon is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Annexon?

The stock symbol for Annexon is "ANNX."

What Is the Annexon Market Cap?

As of today, Annexon market cap is 308.30M.

What Is Annexon's Earnings Per Share (TTM)?

The Annexon EPS (TTM) is -1.16.

When Is the Next Annexon Earnings Date?

Annexon will release its next earnings report on Aug 18, 2025.

From a Technical Analysis Perspective, Is ANNX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Annexon Stock Split?

Annexon has split 0 times.

How Many Employees Does Annexon Have?

Annexon has 106 employees.

What is the current trading status of Annexon (ANNX)?

As of Jul 11, 2025, Annexon (ANNX) is trading at a price of 2.80, with a previous close of 2.77. The stock has fluctuated within a day range of 1.85 to 2.97, while its 52-week range spans from 1.29 to 7.85.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.